Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Experimental models of Parkinson's disease: Challenges and Opportunities

Lal R, Singh A, Watts S, Chopra K.

Eur J Pharmacol. 2024 Oct 5;980:176819. doi: 10.1016/j.ejphar.2024.176819. Epub 2024 Jul 18.

Neuroprotective effects of GLP-1 class drugs in Parkinson's disease

Lv D, Feng P, Guan X, Liu Z, Li D, Xue C, Bai B, Hölscher C.

Front Neurol. 2024 Dec 10;15:1462240. doi: 10.3389/fneur.2024.1462240. eCollection 2024.

Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?

Hölscher C.

Neuropharmacology. 2024 Aug 1;253:109952. doi: 10.1016/j.neuropharm.2024.109952. Epub 2024 Apr 25.

Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction

Tanaka M, Vécsei L.

J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.

Effectiveness of Lee Silverman Voice Treatment (LSVT-LOUD) in Parkinsonian-Type Multiple System Atrophy (MSA-P): A Case Report

Hayashi K, Izumi R, Saito N, Suzuki A, Nakaya Y, Sato M, Kobayashi Y.

Cureus. 2024 Nov 6;16(11):e73106. doi: 10.7759/cureus.73106. eCollection 2024 Nov.

Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue

Turkistani A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, Elfiky MM, Saad HM, Batiha GE.

Mol Neurobiol. 2024 Sep;61(9):7092-7108. doi: 10.1007/s12035-024-04003-z. Epub 2024 Feb 17.

The Relationship between SNAP25 and Some Common Human Neurological Syndromes

Shu J, Peng F, Li J, Liu Y, Li X, Yuan C.

Curr Pharm Des. 2024;30(30):2378-2386. doi: 10.2174/0113816128305683240621060024.

Neuropsychiatric symptoms in Parkinson's disease: review of data from the Arab world

Chabbouh A, Khalil H, Abboud C, Sader A, Khoury R.

J Int Med Res. 2024 Dec;52(12):3000605241304646. doi: 10.1177/03000605241304646.

Effect of Rhythmically Cued Exercise Interventions on Functions in Patients With Parkinson Disease: A Meta-Analysis

Huang X, Dong K, Gan C, Xu Z, Lei D, Dong X, Liu H, Chen X.

Phys Ther. 2024 Mar 1;104(3):pzad158. doi: 10.1093/ptj/pzad158.

Non-Pharmacological Interventions for Depression and Anxiety in Parkinson's Disease

van Wegen EEH, van Balkom TD, Hirsch MA, Rutten S, van den Heuvel OA.

J Parkinsons Dis. 2024;14(s1):S135-S146. doi: 10.3233/JPD-230228.

Intraparenchymal delivery of adeno-associated virus vectors for the gene therapy of neurological diseases

Kumagai S, Nakajima T, Muramatsu SI.

Expert Opin Biol Ther. 2024 Aug;24(8):773-785. doi: 10.1080/14712598.2024.2386339. Epub 2024 Jul 31.

VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress

Wu A, Lee D, Xiong WC.

Expert Opin Ther Targets. 2024 Aug;28(8):701-712. doi: 10.1080/14728222.2024.2392700. Epub 2024 Aug 22.

Self-Management Systems for Patients and Clinicians in Parkinson's Disease Care: A Scoping Review

Boege S, Milne-Ives M, Ananthakrishnan A, Carroll C, Meinert E.

J Parkinsons Dis. 2024;14(7):1387-1404. doi: 10.3233/JPD-240137.

Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents

Patel B, Greenland JC, Williams-Gray CH.

J Parkinsons Dis. 2024;14(7):1283-1300. doi: 10.3233/JPD-240353.

Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy

Nohesara S, Abdolmaleky HM, Thiagalingam S, Zhou JR.

Epigenomics. 2024 Jan;16(1):57-77. doi: 10.2217/epi-2023-0342. Epub 2023 Dec 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias